Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-06-22 Purchase | 2022-06-22 4:55 pm | Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO | 30,000 | $0.57 | $17,100 | 210,207 (Indirect Direct) | View |
2021-04-20 Purchase | 2021-04-21 3:18 pm | Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, CEO & President | 11,005 | $1.8 | $19,809 | 180,207 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-07-11 Option Award | 2022-08-04 4:16 pm | N/A 2032-07-11 | Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman and CEO | 375,000 | $0 | 375,000 (Direct) | View |
2020-06-06 Option Award | 2020-06-08 9:26 pm | N/A 2030-06-06 | Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
2020-05-22 Other | 2020-05-27 6:04 pm | 2020-05-22 2024-01-31 | Qualigen Therapeutics Inc. | QLGN | Poirier Michael S. Chairman, President & CEO. | 257,760 | $0 | 426,952 (Direct) | View |